Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Tanaka

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutationDavid M Waterhouse, Sacha Rothschild, Christophe Dooms, et al.
International Journal of Cardiology|January 10, 2017
Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomographyYusuke Fujino, Guilherme F Attizzani, Satoko Tahara, et al.
Cell Reports|August 2, 2023
Modulation of host glutamine anabolism enhances the sensitivity of small cell lung cancer to chemotherapyManabu Kodama, Gouji Toyokawa, Osamu Sugahara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 6, 2026
Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-BevacizumabToshinori Toyota, Satoshi Narahara, Haruki Uojima, et al.
Journal of the American Heart Association|August 24, 2022
Gut Microbiota and Coronary Plaque CharacteristicsAkihiro Nakajima, Satoru Mitomo, Haruhito Yuki, et al.
Nature Genetics|April 24, 2023
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severityRyuya Edahiro, Yuya Shirai, Yusuke Takeshima, et al.
Annals of Surgical Oncology|July 12, 2025
Functional Outcomes after Subtotal/Total Glossectomy with Microsurgical Reconstruction: A Multicenter Prospective Observational Study in JapanJun Araki, Keita Mori, Yoshichika Yasunaga, et al.
Journal of Thrombosis and Thrombolysis|October 7, 2022
Biomarkers associated with coronary high-risk plaquesAkihiro Nakajima, Peter Libby, Satoru Mitomo, et al.
Cancer Science|May 15, 2023
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407Shunichi Sugawara, Kentaro Tanaka, Fumio Imamura, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutationDavid M Waterhouse, Sacha Rothschild, Christophe Dooms, et al.
International Journal of Cardiology|January 10, 2017
Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomographyYusuke Fujino, Guilherme F Attizzani, Satoko Tahara, et al.
Cell Reports|August 2, 2023
Modulation of host glutamine anabolism enhances the sensitivity of small cell lung cancer to chemotherapyManabu Kodama, Gouji Toyokawa, Osamu Sugahara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 6, 2026
Statin Use Is Associated With Improved Survival But Not Progression-Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab-BevacizumabToshinori Toyota, Satoshi Narahara, Haruki Uojima, et al.
Journal of the American Heart Association|August 24, 2022
Gut Microbiota and Coronary Plaque CharacteristicsAkihiro Nakajima, Satoru Mitomo, Haruhito Yuki, et al.
Nature Genetics|April 24, 2023
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severityRyuya Edahiro, Yuya Shirai, Yusuke Takeshima, et al.
Annals of Surgical Oncology|July 12, 2025
Functional Outcomes after Subtotal/Total Glossectomy with Microsurgical Reconstruction: A Multicenter Prospective Observational Study in JapanJun Araki, Keita Mori, Yoshichika Yasunaga, et al.
Journal of Thrombosis and Thrombolysis|October 7, 2022
Biomarkers associated with coronary high-risk plaquesAkihiro Nakajima, Peter Libby, Satoru Mitomo, et al.
Cancer Science|May 15, 2023
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407Shunichi Sugawara, Kentaro Tanaka, Fumio Imamura, et al.
Pageof 35